Emil Noeggerath, MD, becomes the first gynecologist at The Mount Sinai Hospital.

Joseph Brettauer, MD, and Florian Krug, MD, assume joint leadership of the Department.

Robert Tilden Frank, MD, assumes leadership of the Department.

Robert Tilden Frank, MD, coins the term premenstrual syndrome, also known as PMS.

Morris Goldberger is appointed Chief of the Department.

The Klingenstein Pavilion at Mount Sinai opens, providing the most modern and comprehensive obstetrical and nursery services in New York City.

Alan Guttmacher, MD, becomes Chief of the newly named Department of Obstetrics and Gynecology.

Samuel Geist, MD, serves as Co-Director with Isidor Clinton Rubin, MD, and assumes leadership of the Department upon Rubin's death.

Saul Gusberg, MD, succeeds Alan Guttmacher, MD, as Chairman and Director. Dr. Gusberg establishes the first Gynecological Oncology program and fellowship at Mount Sinai.

The Department starts using ultrasound in its perinatal medicine practice.

Sidney S. Chen, MD, David Koffler, MD, and Carmel J. Cohen, MD, demonstrate the presence of cell-mediated immunity in patients with cervical, ovarian, and endometrial cancers – a finding that would establish a basis for the benefits of immunotherapy.

Howard Bruckner, MD, Carmel J. Cohen, MD, Gunter Deppe, MD, and colleagues are among the first to demonstrate the utility of cisplatin in the treatment of patients with advanced epithelial ovarian cancer and squamous cell carcinoma of the cervix.

Carmel J. Cohen, MD, introduces minimally invasive surgery to the Division of Gynecologic Oncology and adds training in laparoscopic procedures to the fellowship program.

Nathan G. Kase, MD, succeeds Saul Gusberg, MD. A specialist in gynecology and reproductive endocrinology, Kase provides the first demonstration that the human ovary could synthesize testosterone in vitro.

Richard Berkowitz, MD, introduces the modern use of ultrasound to the practice of perinatal medicine at Mount Sinai.

Richard Berkowitz, MD, is appointed Chairman of the newly renamed Department of Obstetrics, Gynecology and Reproductive Science.

The first successful intrauterine transfusion of blood is given by the intravascular route without the use of fetoscopy.

Rhoda Sperling, MD, senior author on the landmark AIDS Clinical Trials Group paper, documents how antiviral therapy used during labor and the neonatal period dramatically reduces vertical transmission of the HIV virus from pregnant women to their babies.

Michael Brodman, MD, becomes the fourth Chairman of the Department of Obstetrics, Gynecology and Reproductive Science.

The Family Planning Division is created at Mount Sinai.

The Blavatnik Family Women's Health Research Institute is established, with Elizabeth Howell, MD, serving as founding Director. The Institute's mission to improve women's health care is supported by its translational research and training future leaders in the field.

Leslee Shaw, PhD, an internationally renowned researcher recognized for her cardiovascular outcomes research on the clinical diagnosis and imaging of ischemic heart disease, succeeds Elizabeth Howell, MD, MPP, as the Director of The Blavatnik Family Women's Health Research Institute.

Joanne Stone, MD, MS, is appointed Chair of the Department, the first female to serve in this role at Mount Sinai.

Led by Joanne Stone, MD, MS, the Mount Sinai-Rainbow Clinic is launched, the first of its kind in the United States. The Rainbow Clinic provides emotional support and enhanced prenatal care to families who have experienced perinatal loss.